Oral Pemphigus during Pregnancy: A Case Report

doi:10.13701/j.cnki.kqyxyj.2024.08.017

Abstract

Abstract: Pemphigus is a severe and chronic autoimmune blistering disorder that typically presents as cutaneous and mucosal blisters and erosions. Pemphigus in pregnancy is rarely reported and may lead to both maternal and fetal complications, so early diagnosis and management are quite crucial to improve outcomes. Herein, we presented a case of pemphigus during pregnancy with lesions confined to oral cavity. The aim of this report was to explore the clinical manifestations, diagnosis, differential diagnosis, and treatment of this rare condition, and to provide a reference for the clinical diagnosis and treatment of this condition.

Key words: pemphigus, pregnancy, diagnosis, treatment

HE Mingjing, SU Zhuizi, ZHOU Gang. Oral Pemphigus during Pregnancy: A Case Report[J]. Journal of Oral Science Research, 2024, 40(8): 749-752.

References

[1] Sadik CD, Schmidt E, Zillikens D, et al. Recent progresses and perspectives in autoimmune bullous diseases [J]. J Allergy Clin Immunol, 2020, 145(4): 1145-1147.
[2] Kardos M, Levine D, Gürcan HM, et al. Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes [J]. Obstet Gynecol Surv, 2009, 64(11): 739-749.
[3] Lan Y, Zhang H, Jin H. Pregnancy in pemphigus vulgaris: A systematic review [J]. Am J Reprod Immunol, 2024, 91(1): e13813.
[4] Yang M, Wu H, Zhao M, et al. The pathogenesis of bullous skin diseases [J]. J Transl Autoimmun, 2019, 2: 100014.
[5] Kershenovich R, Hodak E, Mimouni D. Diagnosis and classification of pemphigus and bullous pemphigoid [J]. Autoimmun Rev, 2014, 13(4-5):477-481.
[6] Feliciani C, Genovese G, D'astolto R, et al. Autoimmune bullous diseases during pregnancy: insight into pathogenetic mechanisms and clinical features [J]. G Ital Dermatol Venereol, 2019, 154(3):256-262.
[7] Singhal S, Meena J, Kumar S, et al. Maternal and perinatal outcomes of pregnancy in women with autoimmune disorder [J]. Cureus, 2021, 13(6): e16024.
[8] Zhao CY, Chiang YZ, Murrell DF. Neonatal autoimmune blistering disease: A systematic review [J]. Pediatr Dermatol, 2016, 33(4): 367-374.
[9] Joly P, Horvath B, Patsatsi A, et al. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV) [J]. J Eur Acad Dermatol Venereol, 2020, 34(9): 1900-1913.
[10] Mahmoudi H, Toosi R, Salehi Farid A, et al. Pemphigus disease and area index: Unmet needs in the real-world management of pemphigus [J]. Oral Dis, 2024, 30(4):2275-2277.
[11] Shamabadi A, Yazdinezhad S, Sadeghi Y, et al. ODSS vs. ABSIS and PDAI oral parts in pemphigus vulgaris: inter-rater reliability and testing times [J]. Oral Dis, 2023, 29(7):2696-2704.
[12] Lin L, Zeng X, Chen Q. Pemphigus and pregnancy. Analysis and summary of case reports over 49 years [J]. Saudi Med J, 2015, 36(9):1033-1038.
[13] 中国医疗保健国际交流促进会皮肤科分会. 寻常型天疱疮诊断和治疗专家建议(2020) [J]. 中华皮肤科杂志,2020,53(1):1-7.
[14] 吴效科,黄志超.主译.舍费尔.著.孕期与哺乳期用药[M].北京:科学出版社,2021.1.302-304.
[15] Temprano KK, Bandlamudi R, Moore TL. Antirheumatic drugs in pregnancy and lactation [J]. Semin Arthritis Rheum, 2005, 35(2): 112-121.
[16] Bostan E, Gülseren D, Ersoy Evans S, et al. Efficacious treatment of pemphigus vulgaris by intravenous immunoglobulin during pregnancy and postpartum period [J]. Dermatol Ther, 2020, 33(1):e13187.
[17] Nasca MR, Giuffrida G, Micali G. The influence of pregnancy on the clinical evolution and prognosis of pre-existing inflammatory and autoimmune skin disorders and their management [J]. Dermatology, 2021, 237(5):771-785.
[18] Murase JE, Heller MM, Butler DC. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy [J]. J Am Acad Dermatol, 2014, 70(3): 401.e1-14; quiz 415.